Rehard Robert 4
4 · REGAL REXNORD CORP · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Regal Rexnord (RRX) CFO Robert Rehard Sells 6,499 Shares
What Happened
- Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord (RRX), sold 6,499 shares in an open-market transaction on May 22, 2026. The shares were disposed at $200.00 per share, for a total value of $1,299,800.
- This was a sale (disposition) rather than a purchase or award; sales are often routine liquidity transactions and do not, by themselves, indicate a change in company outlook.
Key Details
- Transaction date: 2026-05-22; Filing date (Form 4): 2026-05-26.
- Price per share: $200.00; Total proceeds: $1,299,800.
- Shares owned after transaction: Not disclosed in this filing.
- Transaction type/code: Open market sale (S).
- Notable footnotes in the filing:
- F1: Describes a Stock Appreciation Rights vesting schedule (40% at year 2, up to 100% at year 5).
- F2: Describes a different SAR vesting schedule (34% year 1, 67% year 2, 100% year 3).
- Timeliness: The Form 4 was filed four days after the transaction; Form 4s are typically required within two business days (investors may want to note the filing date).
Context
- This report documents a direct sale of shares. It does not show any option exercise or immediate sale following an exercise (i.e., no cashless exercise noted).
- Insider sales can reflect many reasons (tax planning, diversification, routine sales), so this single sale should not be taken alone as a signal about company fundamentals.
Insider Transaction Report
Form 4
Rehard Robert
EVP and CFO*
Transactions
- Sale
Common Stock
2026-05-22$200.00/sh−6,499$1,299,800→ 27,964.953 total
Holdings
- 2,164
Stock Appreciation Rights
[F1]Exercise: $76.99From: 2019-05-10Exp: 2027-05-10→ Common Stock (2,164 underlying) - 7,730
Stock Appreciation Rights
[F1]Exercise: $74.04From: 2020-05-09Exp: 2028-05-09→ Common Stock (7,730 underlying) - 15,382
Stock Appreciation Rights
[F1]Exercise: $78.05From: 2021-05-08Exp: 2029-05-08→ Common Stock (15,382 underlying) - 12,340
Stock Appreciation Rights
[F2]Exercise: $84.39From: 2021-02-18Exp: 2030-02-18→ Common Stock (12,340 underlying) - 9,276
Stock Appreciation Rights
[F2]Exercise: $133.77From: 2022-02-23Exp: 2031-02-23→ Common Stock (9,276 underlying) - 8,292
Stock Appreciation Rights
[F2]Exercise: $151.27From: 2023-02-23Exp: 2032-02-23→ Common Stock (8,292 underlying) - 9,456
Stock Appreciation Rights
[F2]Exercise: $154.20From: 2024-02-23Exp: 2033-02-23→ Common Stock (9,456 underlying) - 7,657
Stock Appreciation Rights
[F2]Exercise: $168.47From: 2025-02-23Exp: 2034-02-23→ Common Stock (7,657 underlying)
Footnotes (2)
- [F1]The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
- [F2]The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
Signature
/s/ Molly Johnson, as Power of Attorney|2026-05-26